Project Grant HT94252310402
Award Date
7/1/23
Completion Date
6/30/25
Dollars Obligated
$300K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Omaha, NE 68198, USA
Similar Awards
This $299,998 Project Grant award was provided by the U.S. Department of Defense's Military Medical Research and Development program (CFDA 12.420) to the University of Nebraska Medical Center (UNMC). The award will support a 2-year research project from July 2024 to July 2026 entitled "VAP-1 AND METHYLGLYOXAL AS NOVEL TARGETS IN LUPUS NEPHRITIS". Through this funding, UNMC will conduct innovative biomedical research to investigate new treatment approaches for lupus nephritis, a...
The Board of Regents of the University of Nebraska was awarded a $2,084,290 project grant from the Department of the Army Medical Command to research the dynamic interaction of airborne biohazards in rheumatoid arthritis-associated lung disease. The grant was awarded on September 30, 2021 under the Military Medical Research and Development program (CFDA 12.420), with a completion date of September 29, 2025. This program supports basic, applied, and advanced biomedical research that transforms...
The federal Project Grant award of $846,220 was provided by the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) to the Board of Regents of the University of Nebraska Medical Center (UNMC) on March 1, 2024. The award supports a 3-year research project titled "The Role of Astrocyte in Sleep Impairments in ASD" that aims to investigate the link between astrocyte function and sleep disturbances in individuals with autism spectrum...
The University of Nebraska Medical Center will receive $1,003,276 under a four-year Project Grant from the Department of the Army Medical Command to support research titled "Dynamic Interaction of Airborne Biohazards in Rheumatoid Arthritis-Associated Lung Disease." The grant is part of the Military Medical Research and Development program (CFDA 12.420), which aims to transform military and public health through innovative biomedical research solutions for battlefield medicine....
This Project Grant award for $750,000.00 from the Defense Health Agency supports the research project titled "ESTROGEN RECEPTOR ALPHA REGULATION OF B-CELL RECEPTOR SIGNALING, B-CELL ACTIVATION, AND PERIPHERAL B-CELL TOLERANCE" at the University of Nebraska Medical Center from July 1, 2023 to June 30, 2027. The research will investigate medical solutions related to B-cell biology and immune response, which aligns with the objectives of the Military Medical Research and Development...
The Defense Health Agency awarded a $386,250 Project Grant to the University of Nebraska Medical Center through the Military Medical Research and Development program (CFDA 12.420) to support research targeting the validation and inhibition of RHNO1 function in ovarian cancer. The two-year award beginning July 1, 2023 will fund preclinical research efforts to investigate medical solutions for ovarian cancer at the molecular level. As the parent organization, the Board of Regents of the University...
This federal Project Grant award of $997,821.00, provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program, supports advanced biomedical research initiatives focused on transforming healthcare for military service members and the general public. The primary awardee, Trustees of Dartmouth College, will conduct research to investigate the pathogenic role of neutrophil subpopulations in lupus nephritis. The project includes sub-awards to The...
The University of Nebraska Medical Center (UNMC) was awarded a $1,544,999.00 Project Grant by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to conduct research on a "NOVEL ER STRESS MITIGATION PATHWAY IN ERBB2-DRIVEN ONCOGENESIS". The grant, which has a performance period from May 1, 2024 to April 30, 2027, will support UNMC's investigation of an innovative pathway for mitigating endoplasmic reticulum (ER) stress in ErbB2-driven...
This $2,000,000 Project Grant awarded by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) federal grant program supports advanced biomedical research on the interrelationship between the PINK1-PRKN pathway disruption and tauopathy in the pathophysiology of cognitive impairment in Parkinson's disease. The grant, awarded to the Board of Regents of the University of Nebraska, through its University of Nebraska Medical Center (UNMC) Division, will fund this...
This Project Grant award of $183,220.00 was provided by the Defense Health Agency under the Military Medical Research and Development federal grant program (CFDA 12.420) to the Board of Regents of the University of Nebraska, through its University of Nebraska Medical Center (UNMC) Division. The award will fund research to target the CCL17/CCR4 axis in order to eradicate lung cancer brain metastasis. The research will be conducted at UNMC in Omaha, Nebraska and is scheduled to run from February...